Screener
Madrigal Pharmaceuticals, Inc. MDGL Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Madrigal Pharmaceuticals, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 9:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050845
FAQ
- What is Madrigal Pharmaceuticals, Inc.'s asset turnover?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported asset turnover of 1.1× in Q2 2026.
- How has Madrigal Pharmaceuticals, Inc.'s asset turnover changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s asset turnover increased by 133.1% year-over-year, from 0.5× to 1.1×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Madrigal Pharmaceuticals, Inc.'s asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude